Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequent Please Neo Extended Post-Market Clinical Follow-up Study

NCT05788432 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT05788432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequent Please Neo Extended Post-Market Clinical Follow-up Study
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Active, not recruiting
Start date
March 28, 2023
Completion date
December 1, 2026
Enrollment
2,040 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemic heart disease